Glass Lewis urges ECAT holders back BlackRock slate, reject Saba dissident nominees

BlackRock ESG Capital Allocation Term Trust

BlackRock ESG Capital Allocation Term Trust

ECAT

0.00

  • Glass Lewis backed BlackRock’s full slate of nine trustee nominees at BlackRock ESG Capital Allocation Term Trust ahead of the June 9, 2026 annual meeting, rejecting a rival slate put forward by activist investor Saba.
  • The proxy adviser cited the fund’s relatively tight discount to net asset value, about 2.8% as of May 15, 2026, citing results it viewed as competitive on discount control.
  • Glass Lewis also pointed to Saba’s reduced ownership, noting it had sold nearly a third of its stake, citing limited evidence of broader shareholder support for its campaign.
  • BlackRock highlighted distribution increases since inception, alongside discount management and share repurchase programs, citing 36% market-price outperformance versus peers since 2023.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BlackRock ESG Capital Allocation Term Trust published the original content used to generate this news brief via Business Wire (Ref. ID: 20260521424151) on May 21, 2026, and is solely responsible for the information contained therein.